» Authors » Antonio E Dager

Antonio E Dager

Explore the profile of Antonio E Dager including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 585
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez-Luna J, Martin P, Dager A, Charry P, Beltran J, Sanchez-Recalde A, et al.
EuroIntervention . 2023 Aug; 19(7):580-588. PMID: 37565470
Background: Transcatheter aortic valve replacement (TAVR) in non-calcified aortic regurgitation (NCAR) is an off-label procedure. The balloon-expandable Myval includes extra-large sizes (30.5 mm and 32 mm) of interest in this...
2.
Fischer Q, Himbert D, Webb J, Eltchaninoff H, Munoz-Garcia A, Tamburino C, et al.
Circ Cardiovasc Interv . 2018 Dec; 11(11):e006927. PMID: 30571207
Background: The impact of preexisting left bundle branch block (LBBB) in transcatheter aortic valve replacement (TAVR) recipients is unknown. The aim of this study was to determine the impact of...
3.
Wassef A, Rodes-Cabau J, Liu Y, Webb J, Barbanti M, Munoz-Garcia A, et al.
JACC Cardiovasc Interv . 2018 Sep; 11(17):1669-1679. PMID: 30190058
Objectives: The authors aimed to determine the procedural learning curve and minimum annual institutional volumes associated with optimum clinical outcomes for transcatheter aortic valve replacement (TAVR). Background: Transcatheter aortic valve...
4.
Wassef A, Alnasser S, Rodes-Cabau J, Webb J, Barbanti M, Liu Y, et al.
Int J Cardiol . 2017 Aug; 245:222-227. PMID: 28760395
Background: Despite rapidly increasing use of TAVR across institutions, limited data is available for the effect of procedural experience on TAVR outcomes. We investigate the relationship between institutional experience and...
5.
Auffret V, Webb J, Eltchaninoff H, Munoz-Garcia A, Himbert D, Tamburino C, et al.
JACC Cardiovasc Interv . 2017 Jul; 10(15):1564-1574. PMID: 28734885
Objectives: This study sought to assess the influence of baseline right bundle branch block (RBBB) on all-cause and cardiovascular mortality as well as sudden cardiac death (SCD) among patients undergoing...
6.
Urena M, Webb J, Eltchaninoff H, Munoz-Garcia A, Bouleti C, Tamburino C, et al.
J Am Coll Cardiol . 2015 Feb; 65(5):437-48. PMID: 25660921
Background: Little evidence exists of the burden and predictors of cardiac death after transcatheter aortic valve replacement (TAVR). Objectives: The purpose of this study was to assess the incidence and...
7.
Jerez-Valero M, Urena M, Webb J, Tamburino C, Munoz-Garcia A, Cheema A, et al.
JACC Cardiovasc Interv . 2014 Sep; 7(9):1022-32. PMID: 25234675
Objectives: The aim of this study was to determine the impact of the degree of residual aortic regurgitation (AR) and acuteness of presentation of AR after transcatheter aortic valve replacement...
8.
Allende R, Webb J, Munoz-Garcia A, de Jaegere P, Tamburino C, Dager A, et al.
Eur Heart J . 2014 May; 35(38):2685-96. PMID: 24796337
Aim: The aim of this study was to determine the effects of advanced chronic kidney disease (CKD) on early and late outcomes after transcatheter aortic valve implantation (TAVI), and to...
9.
Urena M, Webb J, Tamburino C, Munoz-Garcia A, Cheema A, Dager A, et al.
Circulation . 2013 Dec; 129(11):1233-43. PMID: 24370552
Background: Very few data exist on the clinical impact of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation. The objective of this study was to assess the impact of...
10.
Nuis R, Sinning J, Rodes-Cabau J, Gotzmann M, van Garsse L, Kefer J, et al.
Circ Cardiovasc Interv . 2013 Nov; 6(6):625-34. PMID: 24280965
Background: There is scant information on the prevalence and factors associated with preoperative anemia in patients undergoing transcatheter aortic valve implantation (TAVI) and whether it is associated with mortality. We...